References(34)
[1]
Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke 2022, 53(5): 1473–1486.
[2]
Almalki WH, Alghamdi S, Alzahrani A, et al. Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges. Drug Discov Today 2021, 26(3): 826–835.
[3]
Tang CM, Wang C, Zhang Y, et al. Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke. Nano Lett 2019, 19(7): 4470–4477.
[4]
He QY, Ma YZ, Liu J, et al. Biological functions and regulatory mechanisms of hypoxia-inducible factor-1α in ischemic stroke. Front Immunol 2021, 12: 801985.
[5]
Pan SJ, Zhang Y, Natalia A, et al. Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy. Nat Nanotechnol 2021, 16(6): 734–742.
[6]
Czap AL, Sheth SA. Overview of imaging modalities in stroke. Neurology 2021, 97(20 Suppl 2): S42–S51.
[7]
Zhang Y, Zhang GP, Zeng ZL, et al. Activatable molecular probes for fluorescence-guided surgery, endoscopy and tissue biopsy. Chem Soc Rev 2022, 51(2): 566–593.
[8]
Huang JG, Pu KY. Activatable molecular probes for second near-infrared fluorescence, chemiluminescence, and photoacoustic imaging. Angew Chem Int Ed 2020, 59(29): 11717–11731.
[9]
Park SH, Kwon N, Lee JH, et al. Synthetic ratiometric fluorescent probes for detection of ions. Chem Soc Rev 2020, 49(1): 143–179.
[10]
van Putten MJAM, Fahlke C, Kafitz KW, et al. Dysregulation of astrocyte ion homeostasis and its relevance for stroke-induced brain damage. Int J Mol Sci 2021, 22(11): 5679.
[11]
Gutteridge JMC. Iron and oxygen: a biologically damaging mixture. Acta Paediatr 2018, 78: 78–85.
[12]
Puig S, Ramos-Alonso L, Romero AM, et al. The elemental role of iron in DNA synthesis and repair. Metallomics 2017, 9(11): 1483–1500.
[13]
Walsh RJ, Thomas ED, Chow SK, et al. Iron metabolism. heme synthesis in vitro by immature erythrocytes. Science 1949, 110(2859): 396–398.
[14]
Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2012, 61(6): 933–952.
[15]
Waldvogel-Abramowski S, Waeber G, Gassner C, et al. Physiology of iron metabolism. Transfus Med Hemother 2014, 41(3): 213–221.
[16]
Que EL, Domaille DW, Chang CJ. Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem Rev 2008, 108(5): 1517–1549.
[17]
Xuan WM, Pan R, Wei YY, et al. Reaction-based “off-on” fluorescent probe enabling detection of endogenous labile Fe2+ and imaging of Zn2+-induced Fe2+ flux in living cells and elevated Fe2+ in ischemic stroke. Bioconjug Chem 2016, 27(2): 302–308.
[18]
López-Otín C, et al. Proteases: multifunctional enzymes in life and disease. J Biol Chem 2008, 283(45): 30433–30437.
[19]
Gu ZZ, Kaul M, Yan BX, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297(5584): 1186–1190.
[20]
Gawlak M, Górkiewicz T, Gorlewicz A, et al. High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 2009, 158(1): 167–176.
[21]
Klohs J, Baeva N, Steinbrink J, et al. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J Cereb Blood Flow Metab 2009, 29(7): 1284–1292.
[22]
Barber PA, Rushforth D, Agrawal S, et al. Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia. BMC Neurosci 2012, 13: 76.
[23]
Chen SY, Cui JK, Jiang T, et al. Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke. J Cereb Blood Flow Metab 2017, 37(1): 188–200.
[24]
van Duijnhoven SMJ, Robillard MS, Hermann S, et al. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes. Mol Pharm 2014, 11(5): 1415–1423.
[25]
Cai Y, Leng S, Ma YY, et al. Dynamic change of MMP-9 in diabetic stroke visualized by optical imaging and treated with CD28 superagonist. Biomater Sci 2021, 9(7): 2562–2570.
[26]
Hong GS, Antaris AL, Dai HJ. Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng 2017, 1: 10.
[27]
Chang D, Wang YC, Bai YY, et al. Role of P38 MAPK on MMP activity in photothrombotic stroke mice as measured using an ultrafast MMP activatable probe. Sci Rep 2015, 5: 16951.
[28]
Dong H, Sun LD, Yan CH. Energy transfer in lanthanide upconversion studies for extended optical applications. Chem Soc Rev 2015, 44(6): 1608–1634.
[29]
Zhou J, Liu Q, Feng W, et al. Upconversion luminescent materials: advances and applications. Chem Rev 2015, 115(1): 395–465.
[30]
Chan EM, Levy ES, Cohen BE. Rationally designed energy transfer in upconverting nanoparticles. Adv Mater 2015, 27(38): 5753–5761.
[31]
Huang JZ, Li JQ, Zhang XF, et al. Artificial atomic vacancies tailor near-infrared II excited multiplexing upconversion in core-shell lanthanide nanoparticles. Nano Lett 2020, 20(7): 5236–5242.
[32]
Zhang M, Zuo MM, Wang CX, et al. Monitoring neuroinflammation with an HOCl-activatable and blood-brain barrier permeable upconversion nanoprobe. Anal Chem 2020, 92(7): 5569–5576.
[33]
Smith AM, Mancini MC, Nie S. Bioimaging: second window for in vivo imaging. Nat Nanotechnol 2009, 4(11): 710–711.
[34]
Yang XH, Wang Z, Huang HY, et al. A targeted activatable NIR-IIb nanoprobe for highly sensitive detection of ischemic stroke in a photothrombotic stroke model. Adv Healthc Mater 2021, 10(5): e2001544.